The Latest Cardiac and Vascular News
Santa Monica, CA, June 29, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it will be presenting at the Q2 2018 Emerging Medical Technologies Spotlight virtual event, hosted […]
Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has appointed High Lantern Group (HLG) to assist in building a global stakeholder engagement strategy as the Company prepares for commercialization of […]
Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that Mr. Steven (Steve) Chaussy will be joining the company to serve in the role of Chief Financial […]
